Tris Pharma, Inc.
Clinical trials sponsored by Tris Pharma, Inc., explained in plain language.
-
New painkiller shows promise for Post-Surgery relief
Symptom relief CompletedThis study tested a new pain medication called cebranopadol in 240 adults who had moderate to severe pain after bunionectomy (foot surgery). The goal was to see if it works better than a placebo and how it compares to standard painkillers. Researchers measured pain levels, the ne…
Phase: PHASE3 • Sponsor: Tris Pharma, Inc. • Aim: Symptom relief
Last updated Jun 09, 2026 12:07 UTC
-
New pain drug shows promise for tummy tuck recovery
Symptom relief CompletedThis study tested a drug called cebranopadol to see if it safely reduces moderate to severe pain after a tummy tuck (abdominoplasty). About 279 adults took either the drug or a placebo, and researchers measured their pain levels over 48 hours. The goal was to find a better option…
Phase: PHASE3 • Sponsor: Tris Pharma, Inc. • Aim: Symptom relief
Last updated Jun 05, 2026 12:10 UTC
-
New painkiller tested for abuse risk – could it be safer than oxycodone?
Knowledge-focused CompletedThis study tested a new painkiller called cebranopadol to see if it is less likely to be abused than oxycodone. 48 healthy people who have used opioids for fun in the past took the drug, oxycodone, or a placebo by nose. Researchers measured how much they liked each drug to unders…
Phase: PHASE1 • Sponsor: Tris Pharma, Inc. • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:13 UTC